Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000902664-25-004297·89bio, Inc.
Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.001 per share · CUSIP: 282559103
Event date: 2025-09-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adage Capital Management, L.P.Reported CIK 0001535978
Shares: 9,097,587.00 · Class: 6.13%
- Robert AtchinsonReported CIK 0001403404
Shares: 9,097,587.00 · Class: 6.13%
- Phillip GrossReported CIK 0001403413
Shares: 9,097,587.00 · Class: 6.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004297
- Form type
- SCHEDULE 13D
- Filer
- 89bio, Inc.
- CIK
- CIK 1785173
- Filed
- Oct 03, 2025
- Reporting period
- Sep 26, 2025
- Description
- Schedule 13D beneficial ownership